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In this chapter are discussed the use, antitumor mechanisms and potentialities of 
electrotherapy of low-level direct current in cancer. We make emphasis in one of the most 
stimulating problems in the theme of electrotherapy-cancer as is the propose of electrode 
arrays that efficiently distribute the electric current density (electric field) in the tumor and 
its surrounding healthy tissue in order to maximize the tumor destruction with the 
minimum damage to the organism. A mathematical theorem is intended to obtain the 
analytical expressions for three-dimensional electric current density (electric field) generated 
by arrays of electrodes with finite length from those obtained for a point electrodes array. 
The importance and application of these electrode arrays in therapeutic planning are also 
discussed. 
Electrotherapy is based on principles developed during the nineteenth and twentieth 
centuries following the first demonstration of “animal electricity” by Luigi Galvani in the 
eighteenth century. In medicine, the term electrotherapy has been applied to a range of 
alternative medical devices and treatments. Reputable medical and therapy Journals report 
that the use of electrotherapy devices has been widely researched and the advantages have 
been well accepted in the field of rehabilitation and in the treatment of chronic wounds, 
pressure ulcers, pain (improves range of joint movement) and neuromuscular dysfunction 
(improvement of strength, improvement of motor control, retards muscle atrophy and 
improves local blood flow). Also, electrotherapy has been applied in tissue repair (enhances 
microcirculation and protein synthesis to heal wounds and restores integrity of connective 
and dermal tissues), acute and chronic edema (accelerates absorption rate, affects blood 
vessel permeability, and increases mobility of proteins, blood cells and lymphatic flow), 
peripheral blood flow (induces arterial, venous and lymphatic flow), iontophoresis (delivery 
of pharmacological agents), urine and fecal incontinence (affects pelvic floor musculature to 
reduce pelvic pain and strengthen musculature and treatment may lead to complete 
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continence). Yet some of the treatment effectiveness mechanisms are little understood. 
Therefore effectiveness and best practices for their use in some instances are still anecdotal 
[Joa, 2010]. 
On the other hand, the application of electrotherapy in cancerous tissue has been found to 
have a beneficial effect in some cases of cancer. Many different forms of electrical current 
with respect to frequencies, pulse-shapes and amplitudes have been employed in 
biomedicine with the aim of remodeling tissues by enhancing or suppressing cell 
proliferation. One of the scopes is also employment of direct current as an antitumor agent 
[Cabrales et al., 2001; Ciria et al., 2004; Jarque et al., 2007; Ren et al., 2001; Schaefer et al., 
2008; Turler, et al., 2000; Vodovnik et al., 1992; Xin et al., 2004; Yoon et al., 2007]. 
2. Electrotherapy on cancer 
Cancer is uncontrolled cell growth and its cause is not well understood. The tumor cells are 
aggressive (grow and divide without respect to normal limits), invasive (invade and destroy 
adjacent tissues) and metastatic (spread to other locations in the body) [Cohen & Arnold, 
2008]. These malignant properties of cancer differentiate of the benign tumors, which are 
self-limited in the growth and do not invade or metastasize. 
Tumor cells have some structural and physiological characteristics that reveal their electric 
properties, which differ from the ones of the surrounding healthy cells. One of these 
properties is a smaller transmembrane potential, which happens due to the fact that sodium 
and water present an inward flow, while potassium, zinc, calcium and magnesium flow 
outwards. Another of these properties is the accumulation of an excessive amount of 
negative charges in the outer area, which causes the reduction of intracellular potassium 
and the increase of intracellular sodium that lead to a carcinogenic state in the cell. Other 
characteristics are the electric field decrease through the membrane, a greater electrical 
conductivity and permittivity, the existence of abnormal electron-transference systems, the 
negative bioelectrical potentials, the alteration of the normal energy production process 
which uses electron transport and the hydrogen ion gradient through the mitochondrial 
membrane, and finally, the existence of areas with a relative electron deficit [Haltiwanger, 
2008; Joa, 2010]. 
Surgery, chemotherapy, radiation therapy, immunotherapy (vaccines, monoclonal antibody 
therapy, among other) are the conventional therapies for treating cancer [Haltiwanger, 2008; 
Vinageras et al., 2008; Xiang et al., 2008; Xin et al., 2004]. Choice of therapy depends upon 
tumor characteristics (location, histological variety, size and stage) and state of patient. 
However, these conventional therapies have major side effects, have no given a complete 
solution to the cancer problem, and are costly too. Hence attractive alternative, affordable, 
effective treatments are sought and one of the upcoming treatments is the use of electrical 
therapies, as electrochemotherapy [Sadadcharam et al., 2008] and electrotherapy [Cabrales 
et al., 2010]. The characteristics of tumor cells above mentioned may prevent the reparation 
and re-establishing of the normal metabolic functions of the tumor cell, but, on the other 
hand, they facilitate the anti-tumor action of the electrotherapy. 
2.1 Preclinical and clinical studies 
Electrotherapy consists in the application of a low-level direct current to the solid tumor by 
means of the electrodes (i.e., platinum, platinum-iridium 90/10, stainless steel). The needles 
are connected to an electrical device that produces a direct current, which is generated by an 
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applied voltage between two electrodes. The needles with a positive charge are named 
anodes, while the needles with a negative charge are the cathodes. Different shapes of 
needles are used for treatment of tumors in dependence of the size and constitution of the 
tumor type. Harder needles are used to treat superficial tumors (breast, skin, melanoma 
cancers) [Jarque et al., 2007; Xin et al., 2004] and more elastic needles are used to treat 
visceral tumors (lung, liver, esophageal, prostate and rectal cancers) [Chou et al., 1997; Vogl 
et al., 2007; Xin et al., 2004; Yoon et al., 2007]. The location of the tumor should be 
determined before treatment. It and the tumor size are determined by palpation with hand 
for the case of superficial tumors; however, in visceral tumors are determined by means of 
computer tomography, X ray, Imaging Nuclear Magnetic Resonance and/or ultrasound. 
Normally, the treatment with electrotherapy is carried out under local anesthetic and on an 
outpatient basis. The tumor size determines how many needle electrodes are required, 
which are introduced into the tumor through the skin. 
Many physicians have successfully used electrotherapy, also known as electrochemical 
tumor therapy, Galvanotherapy and electro-cancer treatment, as a standalone treatment in 
thousands of cases, with some truly spectacular results. There are many potential 
advantages of electrotherapy over conventional treatments, such as: (1) Direct current is 
suitable for all types of superficial or visceral tumors, both malignant and benign. (2) This 
therapy is easy to perform, safe, effective, inexpensive, induces minimum damages to the 
organism, can be carried out on an out-patient basis and it can be applied when the 
conventional therapies fail or cannot be applied. (3) It may be best suitable for cancers near 
critical organs where surgery and/or radiation therapy have failed or could not be 
performed without damaging other normal parts. (4) This therapy not only reduces costs of 
chemotherapy, radiotherapy, hyperthermia and immunotherapy, but also improves 
compliance. (5) Electrotherapy may be suitable for nonresectable tumors and can save 
functional tissues [Jarque et al., 2007; Vogl et al., 2007; Xin et al., 2004; Yoon et al., 2007]. (6) 
The tumor and its surrounding healthy tissue have different electric and geometrical 
parameters [Aguilera et al., 2010; Cabrales et al., 2010; Foster, 2000; Foster & Schwan, 1996; 
Haemmerich et al., 2003; Haemmerich et al., 2009; Haltiwanger, 2008; Jiménez et al., 2011; 
Ng et al., 2008; Sekino et al., 2009; Seo et al., 2005; S.R. Smith et al., 1986; D.G. Smith et al., 
2000], which enable electrically-mediated treatments to be more efficient for a given dose 
and the tumor tissue is more susceptible to damage from direct current than normal tissue, 
thus allowing the destruction of cancerous cells to occur when direct current is applied 
directly to the malignant tissue [Cabrales et al., 2001; Ciria et al., 2004; Jarque et al., 2007; 
Von Euler, 2003]. These are reasons for moving to direct current (electric field) method for 
treating cancer. Judging by the very positive therapy results, it can be assumed, that 
electrotherapy will become an important form of treatment for malignant diseases. In spite 
of these advantages, this therapy cannot be used on ascitic and hemolimphoyetic system 
tumors [Xin et al., 2004]. 
The first time that the insertion of electrodes in the base of the tumor significantly increases 
its destruction rate and decreases the damages to the body after the electrotherapy is 
published in 1997 [Chou et al., 1997]. Their report claims that this way of inserting the 
electrodes and alternating the sequence of cathodes and anodes induces a uniform electric 
field in the whole tumor, which causes a significant destruction of it. They also report that 
the ratio of the number of electrodes to the size of the tumor, taking into account the 
effective area with necrosis around the electrodes (2 cm). Since that research is conducted, 
most scientists have been using this type of data configuration. 
www.intechopen.com
 Current Cancer Treatment – Novel Beyond Conventional Approaches 
 
588 
Electrotherapy antitumor effectiveness can be enhanced when it is combined with 
intratumor injection of a chemostatic drug (i.e., bleomycin, cisplatin) [Jarque et al., 2007; Xin 
et al., 2004], saline solution [Jarque et al., 2007; Lin et al., 2000] and/or immunotherapy 
[Serša et al., 1990; Serša et al., 1992; Serša et al., 1994; Serša et al., 1996]. It has been 
demonstrated that intratumor bleomycin (cisplatin) treatment is more effective than 
intravenous treatment at the same dose and direct current potentiates the antitumor 
effectiveness of bleomycin several-fold [Xin et al., 2004]. 
In vitro and in vivo studies have demonstrated that an increase of direct current (voltage) 
intensity leads to an increase of electrotherapy antitumor effectiveness, as shown in Figure 
1. This figure shows the Ehrlich tumor growth kinetics for the control group (CG) and 
different treated groups: TG1 (treated group with electrical charge of 6.7 mA for 45 min), 
TG2 (treated group with 11.7 mA for 45 min), and TG3 (treated group with 17 mA for 45 
min). The minimum of the amount of volumetric electric charge required for the tumor 
destruction must be 35 coulombs/cm3; however, high antitumor effectiveness is obtained 
when this physical magnitude is between 80 and 100 coulombs/cm3 [Jarque et al., 2007; Ren 
et al., 2001; Xin et al., 2004; Yoon et al., 2007], in agreement with 92 and 80 coulombs/cm3 for 
which the Ehrlich (TG3 in Figure 1) and fibrosarcoma Sa-37 tumors are completely 
destroyed, respectively [Ciria et al., 2004]. 
 
 
Fig. 1. Experimental data (mean ± standard deviation) and modeled growth curves of 
Ehrlich tumor. Each experimental group is formed by 10 mice. CG (control group), TG1 
(treated group with electrical charge of 6.7 mA for 45 min), TG2 (treated group with 11.7 
mA for 45 min), and TG3 (treated group with 17 mA for 45 min). When the tumors reached 
approximately 0.5 cm3 in BALB/c mice, a single shot electrotherapy was supplied (zero 
day). 
In 1978 the clinical use of direct current in the treatment of malignant tumors in humans is 
reported for the first time when Nordenström treated patients with lung cancer and 
explained that the anti-tumoral effects were due to the toxic products that came from the 
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electrochemical reactions induced on it because of the cytotoxic action of electrotherapy. 
Since Nordenström develops his work, the use of electrotherapy has been expanded for the 
treatment of patients with various histological types of cancer in other hospitals of Sweden 
and in different countries, as: China, Germany, Japan, Korea, Australia, Slovenia, the United 
States, Greece, Denmark, France, Brazil, Israel, Russia, Argentina and Cuba. 
Since 1987 the electrotherapy has been used in China for the treatment of malignant and 
benign tumors, and so far it has been applied to over 20,000 patients. This is, therefore, the 
most complete clinical study to date. In the beginning, the group of researchers from China 
[Xin et al., 2004] changes the methodology for placing Nordenström’s electrodes. Instead of 
placing one cathode in the tumor and one anode far from it, they insert several anodes in the 
center of the tumor and the same number of cathodes in the outer zone at the periphery of 
the tumor. Then, they modify again their electrode placing technique, and place the anodes 
and cathodes inside the tumor with the anodes in the center and the cathodes in the 
periphery. This change not only protects the normal tissue from destruction but also 
reinforce the effect of the therapy effect. The electrode placing technique is changed one 
more time by these researchers, when they place anodes and cathodes in an alternate way 
along the tumor volume, setting them 2 cm away from each other, just as is previously 
suggested by other authors [Chou et al., 1997]. 
In June 2005, electrotherapy is used for the first time in Cuba, under the supervision of Dr. 
Li Jing-Hong from the China-Japan Friendship hospital, located in China, for the treatment 
of patients with malignant and benign tumors [Jarque et al., 2007]. The study intends to test 
the electrode insertion procedures and the correct choice in electric charge amount in 
patients having advanced local tumors who are not recommended for conventional 
oncology treatment. The study also intends to evaluate the effectiveness and safety of the 
method. In 1997, Cabrales et al. conducted the first investigations in Cuba on the anti-
tumoral effects of electrotherapy, using experimental murine tumors (Ehrlich and 
fibrosarcoma Sa-37 tumors) in BALB/c, NMRI and C57BL/6 mice. Studies carried out in rats 
are planned to evaluate the safety and the effects induced by the electrotherapy in tumors 
and in the body, taking into account the electric charge doses, as well as the number, 
polarity and orientation of the electrodes, the size and type of the murine tumor and the 
body characteristics [Cabrales et al., 2001; Ciria et al., 2004; Joa et al., 2010]. 
In clinical studies, the patient experiences a slight pressure pain or a slight tingling in the 
treated area during the electrotherapy application. Direct current brings about long lasting 
pain relief because it inhibits the activity of sensory nerve fibers. In the literature are 
reported different adverse events (effects), as: fever, wound infections, damages to the blood 
vessels when the electrodes are inserted close of these [Arsov et al., 2009; Haltiwanger, 2008; 
Jarque et al., 2007; Li et al., 2006; Salzberg et al., 2008; Vijh, 2006; Vogl et al., 2007; Xin et al., 
2004; Yoon et al., 2007]. 
The underlying mechanisms more widely accepted are the toxic products from of the 
electrochemical reactions and change of pH. When low voltage (4 to 10 volts) and low 
amperage (40 to 100 mA) direct currents are administered the tumor area around the anode 
becomes highly acidic due to the attraction of negatively charged chloride ions and the 
formation of hydrochloric acid (pH < 3). The tumor areas around the cathode become highly 
basic (pH > 10) due to the attraction of positively charged sodium ions and the formation of 
sodium hydroxide. Also, chlorine gas and hydrogen gas emerge from the entry points of the 
anodes and cathodes, respectively. The pH change depolarizes cancer cell membranes and 
causes tumors to be gently destroyed [Li et al., 1997; Turjanski et al., 2009; Veiga et al., 2005; 
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Von Euler et al., 2003]. This suggests that the application of direct current (electric field) 
causes electrolysis, electrophoresis, electro-osmosis and electroporation in biological tissues, 
which create micro-environmental chemical changes and micro-electrical field changes 
[Haltiwanger, 2008; Li et al., 1997]. The chemistry of the microenvironment of healthy cells, 
injured cells and cancerous cells and the micro-electrical field of these cells are interrelated 
[Haltiwanger, 2008]. 
In a previous study [Li et al., 1997] is reported the existence of a group of biochemical 
alterations around the anode and cathode in tumors under treatment. Around the anode 
they find a pH of 2, acid hemoglobin, tissue hydration, hydrogen ions that are the result of 
water electrolysis, and oxygen and chlorine gas emissions. From these emissions they 
explain the formation of hydrochloric acid and the acid pH. In the cathode, meanwhile, they 
report a pH of 12, tissue dehydration, hydroxyl ions, which are the result of water 
electrolysis, and hydrogen gas emissions, from which they explain the formation of sodium 
hydroxide responsible for the basic pH. Halfway between the electrodes and far from them, 
no significant differences are observed between the pH and the water concentration in 
tumors treated with electrotherapy, and those in the untreated tumors. They conclude, then, 
that the electrochemical effects of this therapy happen around the electrodes. 
Other antitumor mechanisms have been reported in the literature, such as: (1) immune 
system stimulation after treatment (the attraction of white blood cells to the tumor site) 
[Cabrales et al., 2001; Ciria et al., 2004; Jarque et al., 2007; Serša et al., 1996]; (2) lost of tissue 
water for electro-osmosis [Li et al., 1997; Vijh, 2004, 2006]; (3) change in the membrane 
potential of tumor cells, nutrient uptake by tumor cells and reduce deoxyribose nuclei acid 
production by tumor cells [Chou et al., 1997; Haltiwanger, 2008]; (4) both electrochemical 
reactions (fundamentally those in which reactive oxygen species are involved) and immune 
system stimulation induced by cytotoxic action of the direct current, could constitute the 
most important antitumor mechanisms [Cabrales et al., 2001]; (5) direct current treatment 
increases the expression of dihydronicotinamide adenine dinucleotide phosphate 
dehydrogenase (NADPH) oxidase subunits-derived reactive oxygen species which 
subsequently induces apoptosis of oral mucosa cancer cells [Wartenberg et al., 2008]. These 
authors also report that an increase of the reactive oxygen species brings about an increase 
of the expression of heat shock protein (Hsp 70) and Cu/Zn superoxide dismutase (anti-
oxidative enzymes) and a decrease of intracellular concentration of reduced glutathione, 
whereas the expression of catalase remains unchanged. 
Some authors evidence apoptosis as tumor dead mechanism after direct electric application 
[Wartenberg et al., 2008]; however, other report apoptosis and necrosis around anode and 
necrosis around cathode [Von Euler et al., 2003; Haltiwanger, 2008]. Our experience reveal 
that the morphologic pattern of necrotic cell mass is the coagulative necrosis 24 hours after 
direct current application [Cabrales et al., 2001; Ciria et al., 2004; Jarque et al., 2007]. Also, 
we observe in preclinical and clinical studies vascular congestion, peritumoral neutrophil 
infiltration, an acute inflammatory response, and a moderate peritumoral monocyte (and 
macrophages) infiltration, in agreement with other authors [Chou et al., 1997; Li et al., 1997; 
Serša et al., 1996; Vijh, 2004; Xin et al., 2004]. We are the opinion that apoptosis, necrosis and 
the electrochemical reactions into tumor (mainly around electrodes) may be explained from 
reactive oxygen species. 
We do not reject the possibility that the electric current density induced into the tumor may 
affect (directly or indirectly) the cellular membrane, and intracellular and extracellular 
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spacing that lead to irreversible damages in it. This statement may be corroborated because 
it has been reported that direct electric current can have significant effects on the symmetry 
of surface charge, resulting in a change in membrane potential. Electric fields can produce a 
redistribution of cell surface receptors and influence the flow of specific ions through 
plasma membrane ion channels [Salzberg et al., 2008; Schaefer et al., 2008]. Any change in 
the flow of ions through cellular ion channels can have significant effects on cellular 
metabolism, proliferation rate, cytoplasmic pH, mobility, cell cycle transitions, and 
apoptosis. Also, research shows that direct electric current application can provide electrons, 
helping thus to reestablish the biocurrent flows in cancer tissues that are electrically 
resistant, which brings about the reduction of the resistance, the reestablishing of the 
transmembrane potential in cancer cells, and the concentration of the sodium, potassium, 
chlorine and magnesium ions through cell repolarization [Haltiwanger, 2008]. On the other 
hand, it has been proved that some cell membrane structures can be influenced by the action 
of the electrical current, the electric field or the accumulated charge. These findings are also 
found in vitro studies [Haltiwanger, 2008; Joa, 2010; Yen et al., 1999]. 
Electrotherapy is not implemented in the Clinical Oncology because it is not standardized 
and its antitumor mechanism is poorly understood. The first reason is explained because the 
dosage guideline is arbitrary and dose-response relationships are not established. Also, 
different electrode placements are used and optimal electrode distribution has not been 
determined [Aguilera et al., 2010; Cabrales et al., 2010; Jiménez et al., 2011; Joa et al., 2010]. 
The standardization of this therapy from experimental point of view is complex, 
cumbersome, requires excessive handling of animals, and expensive in resources and time. 
That is why the mathematical modeling constitutes the core of this chapter. 
2.2 Mathematical modeling on electrotherapy: electrode arrays 
Computer modeling and simulation keep growing in the more important fields of 
mathematics and physics applied to biophysics, biology, biochemistry and bioengineering. 
The reasons for this growing importance are manyfold. Among them, the mathematical 
modeling has been shown to be a substantial tool for the investigation of complex 
biophysical, as the cancer. The cancer phenomenon continues to challenge oncologists. The 
pace of progress has often been slow, in part because of the time required to evaluate new 
therapies. To reduce the time to approval, new paradigms for assessing therapeutic efficacy 
are needed. This requires the intellectual energy of scientists working in the field of 
mathematics and physics, collaborating closely with biologists and clinicians. This 
essentially means that the heuristic experimental approach, which is the traditional 
investigative method in the biological sciences, should be complemented by a mathematical 
modeling approach [Bellomo et al., 2008; Cabrales et al., 2010]. 
The mathematical modeling has been little exploded in the electrotherapy-cancer topic. 
Some studies have been focused to propose theoretical models and computer simulations in 
order to describe the tumor growth kinetics [Cabrales et al., 2008; Cabrales et al., 2010; 
Miklavčič et al., 1995]. Predicting tumor growth is important in the planning and evaluation 
of screening programs, clinical trials, and epidemiological studies, as well as in the adequate 
selection of dose-response relationships regarding the proliferative potential of tumors. 
Thus, it is apparent that theoretical mathematical models are needed to study cancer 
[Bellomo et al., 2008; Brú et al., 2003; Jiang, 2009; Mohammadi et al., 2009; Stein et al., 2008]. 
A modification to the Gompertz equation, named modified Gompertz equation, is made to 
describe the experimental data of Ehrlich and fibrosarcoma Sa-37 tumor growth kinetics 
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treated with different direct current intensities [Cabrales et al., 2008]. Fitting the 
experimental data of CG, TG1, TG2 and TG3 with this modified equation (solid line in 
Figure 1) suggests that it is feasible to describe the data of untreated and direct current 
treated tumors. This is also sustained for the small values of the sum of squares of errors 
(SSE), standard error of the estimate (SE), adjusted coefficient of multiple determination 
( 2ar ), predicted residual error sum of squares (PRESS), multiple predicted residual sum 
error of squares (MPRESS) and the errors of each parameter of this equation. This modified 
Gompertz equation establishes the analytical conditions for which are reached the four 
tumor responses types after treatment (progressive disease, stable disease, partial response 
and complete response) and it theoretically corroborates that the electrotherapy antitumor 
effectiveness increases with the increase of the direct current intensity, as shown in Figure 2 
[Cabrales et al., 2008]. Also, this equation theoretically reveals a new antitumor response, 
named stationary partial response and that these different tumor responses depend on the 
ratio between the electric current applied to the tumor (i) and that induced in it (io), named 
i/io ratio, keeping constant the other parameters of this equation, such as: the initial volume 
(Vo), the intrinsic growth rate of the tumor (Ǐ), the growth deceleration factor (ǐ) related to 
the antiangiogenic process the growth deceleration factor related to the antiangiogenic 
process and the duration of the net effect induced in the solid tumor after treatment (1/Ǒ). 
 
 
Fig. 2. Simulation of modified Gompertz equation for Ǐ = 0.6 days-1, ǐ = 0.2 days-1, Ǒ = 0.016 
days-1, io  = 5 mA, Vo = 0.5 cm3 and different magnitudes of i (mA) [Cabrales et al., 2008]. 
From modified Gompertz equation, it is easy to verify that the complete and stationary 
partial responses are reached for i/io > 2 and i/io = 2, respectively. This suggests the 
existence of a threshold value of i/io ratio that may be related with the tumor reversibility 
condition. The tumor complete remission after direct current application suggests that the 
tumor growth kinetic is completely reversible, as is demonstrated in a previous study. The 
stationary partial response is characterized first by a significant decrease of the tumor 
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volume until a certain size, from which it remains constant in the time, fact that may be 
explained because the organism governs the equilibrium with this small tumor volume that 
survived to the direct current cytotoxic action. This tumor response type may suggest that 
the cancer may be a controllable chronic disease [Cabrales et al., 2010]. 
On the other hand, the mathematical modeling has been used to understand alterations on 
cellular membrane [Kotnik & Miklavčič, 2006], the role of pH in electrotherapy [Turjanski et 
al., 2009], the possible physicochemical reactions induced into the tumor during direct 
current application [Nilsson & Fontes, 2001] and the design of an one-probe two-electrode 
device in combination with a 3D gel model that contains the cathode and the anode very 
close to each other (0.1 cm) for studying pH spherical fronts and destroy a cancer cell 
spherical casket [Olaiz et al., 2010]. Also, the mathematical modeling constitutes a rapid way 
to propose an optimum electrodes array or close to it, in function of their parameters and 
those of tumor (localization, size, shape and consistency), using both analytical and 
numerical solutions. This allows the visualization of the potential, electric field intensity and 
electric current density distributions generated electrodes arrays in two-dimensional (2D) 
and three-dimensional (3D) tumors, in order to induce the highest electrotherapy 
effectiveness (higher tumor destruction with the minimum damage to the organism) 
[Aguilera et al., 2009; Aguilera et al., 2010; Čorović et al., 2007; Dev et al., 2003; Jiménez et 
al., 2011; Joa, 2010; Reberšek et al., 2008; Šel et al., 2003]. This later increases our 
understanding about the current flow inside tumor during direct current application. This is 
important because monitoring the current flow during aforementioned therapy is a 
challenging task due to the lack of available noninvasive electrical imaging techniques. We 
support that the direct current strength and its form of distribution, through electrodes, 
have potential biomedical applications and a decisive role in the electrotherapy effectiveness 
[Cabrales et al., 2010; Jiménez et al., 2011]. 
2D-electrode arrays are useful for planar tumors (basal cell carcinoma of the skin, cutaneous 
lymphoma, gastric cancer in its form of delinitis, and melanoma in clinical superficial 
extension) and the potential, electric field strength and electric current density distributions 
that these induce in the tumor are reported for electrodes circular array [Čorović et al., 2007; 
Dev et al., 2003; Šel et al., 2003] and electrodes elliptical array [Aguilera et al., 2009; Aguilera 
et al., 2010]. The explicit dependence of how electric current density distributions depend on 
the ellipse eccentricity, the ratio between the electric conductivities of the solid tumor (σ1) 
and the surrounding healthy tissue (σ2), named σ1/σ2 ratio, and positioning of the electrodes 
with respect to tumor-surrounding healthy tissue interface is shown in Figures 3 and 4 for 
an electrodes circular array (eccentricity = 0) and an electrodes elliptical array (eccentricity = 
0.85), respectively [Aguilera et al., 2010]. In Figures 3a,d and Figures 4a,d, the electrodes are 
inserted in the tumor-surrounding healthy tissue interface. Electrodes inserted inside tumor 
are represented in Figures 3b,e and Figure 4b,e while those inserted in the surrounding 
healthy tissue are depicted in Figures 3c,f and Figures 4c,f. The influence of σ1/σ2 ratio on 
the electric current density distribution is evidenced for σ1/σ2 = 1 (Figures 3a-c and Figures 
4a-c) and σ1/σ2 = 10 (Figures 3d-f and Figures 4d-f). The other parameters of the electrodes 
array are constant, such as: electrode radius (a), electrode potential (Vo), electrode polarity 
(red for the positive electrode, anode, and blue for the negative electrode, cathode), the 
angular separation between two adjacent-electrodes (θ), major radius (b1) and minor radius 
(b2) of the electrodes array, which are related by means of the eccentricity of it. 
www.intechopen.com




Fig. 3. Distributions of the electric current density, in leading-order, J0(x,y), and first-order 
term, J1(x,y), for an electrodes circular array (eccentricity = 0) for: (a) Configuration 1, b1 = b2 
= 0.5 cm, and σ1/σ2 = 1; (b) Configuration 2, b1 = b2= 0.4 cm, and σ1/σ2 = 1; (c) Configuration 
3, b1 = b2= 0.6 cm, and σ1/σ2 = 1; (d) Configuration 1, b1= b2= 0.5 cm, and σ1/σ2 = 10; (e) 
Configuration 2, b1= b2= 0.4 cm, and σ1/σ2 = 10; and (f) Configuration 3, b1= b2= 0.6 cm. 
These simulations are made for θ = 60o, a = 0.0215 cm, Vo = + 0,5 V for the electrodes 2 and 3, 
Vo = – 0,5 V for the electrodes 5 and 6, and Vo = 0 V for the electrodes 1 and 4. The 











Fig. 4. Distributions of the electric current density, in leading-order, J0(x,y), and first-order 
term, J1(x,y), for an electrodes elliptical array with eccentricity = 0.85 for: (a) Configuration 1, b1 
= 0.9492 cm and b2 = 0.5 cm, and σ1/σ2 = 1; (b) Configuration 2, b1 = 0.7593 cm and b2= 0.4 cm, 
and σ1/σ2 = 1; (c) Configuration 3, b1 = 1.1390 cm and b2 = 0.6 cm, and σ1/σ2 = 1; (d) 
Configuration 1, b1= 0.9492 cm and b2 = 0.5 cm, and σ1/σ2 = 10; (e) Configuration 2, b1= 0.7593 
cm and b2 = 0.4 cm, and σ1/σ2 = 10; and (f) Configuration 3, b1 = 1.1390 cm and b2 = 0.6 cm, and 
σ1/σ2 = 10. These simulations are made for θ = 60o, a = 0.0215 cm, Vo = + 0,5 V for the electrodes 
2 and 3, Vo = – 0,5 V for the electrodes 5 and 6, and Vo = 0 V for the electrodes 1 and 4. The 
parameters a, b1, b2 (in centimeter) are converted to meter. 
In order to get more accurate insight of electric current density (potential and electric field 
intensity) distribution inside tumor with complex geometries, 3D modeling is studied 
because, in general, the solid tumors are volumetric. In extending both analytical solution 
and computational techniques for electric current density from 2D to 3D additional 
complexities arise, not only because of the 3D geometries but also from the physical nature 
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tissues. 3D solutions are very expensive and should only be undertaken after simpler 
models have been explored, e.g. the 2D cross-section for the end region for a solid tumor. 
There are different analytically ways to calculate the electric current density (electric field) 
distributions in tissues, as the method based on Green´s theorem (to obtain solutions inside 
defined volumes in terms of surface values of potential and the normal derivate of potential) 
and the Clifford analysis (it allows the matching of the electric fields across boundaries 
separating different conductivity regions with the help of the Clifford product) [Krüger & 
Menzel, 1996]. We have recently published the analytic solutions that visualize 3D 
stationary electric current density as a function of the electrode length, tumor size and the 
conductivities of the tumor (spheroid) and the surrounding healthy tissue (infinite medium) 
generated by a radial electrode array [Jiménez et al., 2011]. This mathematical formalism is 
only valid for electrodes inserted along tumor diameters. This particular electrodes 
configuration may be obtained from a mathematical theorem that allows the calculus of 3D 
electric current density generated by an array of electrodes with arbitrary shape inserted in 
an arbitrary region from 3D electric current density induced by a point current source. This 
guarantees that the electrodes may be inserted in any place of the tumor. 
2.2.1 3D stationary electric current density generated by a wire from a point current 
source 
There is a three-dimensional, conductive, heterogeneous region consisting of two  
linear, homogeneous, isotropic media separated by an interface Σ. Medium 1 of constant 
mean conductivity σ1 (in S/m) and Medium 2 of constant mean conductivity σ2 (in S/m)  
are considered as homogeneous conducting media, as shown in Figure. 5a for the point 
current source and in Figures. 5b,c for a wire of length L, which are inserted inside the 
Medium 1. 
2.2.2 Point current source 
We consider that current is continuous and the magnetic field associated to it may be 
neglected (≤ 0.02 Gauss) then the calculus of the potential ϕ in the point rf  generated by a 




 (Figure 5a) 










⎧∇ = − −⎪⎨⎪∇ =⎩
f fI
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⎧ =⎪⎪ ∂ ∂⎪ =⎨ ∂ ∂⎪⎪ < ∞⎪⎩r
n n
 (2) 
where ϕ Σi  and ˆϕ ∑∂ ∂i n  (i = 1, 2) are the potential and its normal derivative in the surface Σ 
that separate both mediums. 
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Fig. 5. Schematic representation of (a) a point electrode, (b) a wire subdivided in N small 
pieces of longitude δl and (c) a whole wire with ends ( )1tγf  and ( )2tγf  located in the 
Medium 1 of conductivity σ1 surrounded of a Medium 2 of conductivity σ2. The axis y is 
perpendicular to the paper (toward us out of the page). 
2.2.3 Electrode in form of wire of length finite 
Instead of a point current source we now assume the case of a wire of length L (Figure 5c) 
analytically represented for the following parametric differentiable form of the curve ( )tγf of 
parameter t 
 ( ) ( ) ( ) ( )( ), ,t x t y t z tγ =f , [ ]1 2,t t t∈  (3) 
The wire is subdivided in N small pieces of longitude δl (Figure 5b), so that the first 
equation of the system (1) can re-write as 








ψ δ γ δσ =
∇ ≈ − −∑ f f  (4) 
with 
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where ψ1 is the potential generated in the tumor by the wire electrode. d dtγf  is the modulus 
of the tangent to ( )tγf  in Cartesian coordinates, Δt = (t2-t1)/N is the variation of t. When Δt → 0 




































⎧ =⎪⎪ ∂ ∂⎪ =⎨ ∂ ∂⎪⎪ < ∞⎪⎩
 (6) 
where ψ1 and 1 nˆψ∂ ∂  are the potential and normal derivative of the potential in Medium 
1, respectively. ψ2 and 2 nˆψ∂ ∂   are these magnitudes but in Medium 2. nˆ  is the unit 
normal vector to the surface Σ (directed from Medium 1 to Medium 2). δ is the Dirac delta. 
r
f
 is the position of the spherical coordinate. 
The solution of the Problem 1 may be expressed in a very simple way starting from the 
solution of the Problem 0 by means the following theorem 
2.2.4 Theorem  
Let be ( )0,i r rϕ f f , i = 1,2, the solution of the Problem 0. Then, the solution of the Problem 1 is 








r r t dt
L dt
γψ ϕ γ= ∫
ff f f
 (7) 
The demonstration is immediate simply if we substitute (7) in (5) and (6). Substituting (7) in 
(5) results 
 ( ) ( )( ) ( )( )2 2
1 1





r r t dt r t dt
L dt L dt
γ γψ ϕ γ ϕ γ∇ = ∇ = ∇∫ ∫
f ff f f f f  (8) 
www.intechopen.com
 Electrotherapy on Cancer: Experiment and Mathematical Modeling 
 
599 
Making ( )0r tγ=f f  in (1) and substituting in (8) result (5). Also, it can be demonstrated that 
(7) satisfies the boundary conditions (6). 
To illustrate the theorem above mentioned, we use the particular case of a radial electrode 
array proposed in a previous study [Jiménez et al., 2011]. A three-dimensional, conductive, 
heterogeneous region consists of two linear, homogeneous, isotropic media (tumor and the 
surrounding healthy tissue) separated by an interface Σ. Solid tumor (Medium 1) is 
considered as a homogeneous conducting sphere of radius R (in m) and constant mean 
conductivity σ1 (in S/m). The surrounding healthy tissue (Medium 2) is supposed to be a 
homogeneous infinite medium of constant mean conductivity σ2 (in S/m), as shown in 
Figure 6a. 
Point electrode and wire are inserted in plane y = 0 m along tumor diameters and in (r0,0,0), 
using the system of spherical coordinates with the origin in the center of the sphere, as 
shown in Figures 6b (one current source) and 6c (two current sources), respectively. In the 
particular case that both electrode types are located in the axis z (the radial coordinate in 
spherical coincides with axis z of the Cartesian coordinate or (0,0,r0)). 
 
 
Fig. 6. (a) Spherical tumor of conductivity σ1 (in S/m) and radius R (in m) surrounded by its 
healthy tissue of conductivity σ2 (in S/m) and separated by the interface Σ. (b) A point 
electrode (positive) and an electrode with form of wire (positive) are inserted along tumor 
diameter (plane y = 0 cm). (c) Two point electrodes 1 (one positive and another negative) 
and two electrodes with form of wire (one positive and another negative) are inserted along 
tumor diameter (plane y = 0 cm). 
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As the point electrode is located in the tumor along the axis z (left picture in Figure 6a), the 
solution of the Problem 0 is given by 
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The coefficients An and Bn are obtained of the boundary conditions (2), resulting 
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Starting from (11) and (12), corresponding to a point electrode, we can pass to the solution  
of the potential generated by a wire with ends in a and b inserted in the tumor along the  










In this case, L = b-a and 1d dtγ =f . Substituting (13), L and d dtγf  in (7), we obtain the 
solutions for the wire, given by 
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Integrating (14) and (15) from t = a to t = b, we have 
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The superposition principle is used when two (Figs. 6c,d) or more current sources are 
inserted in the tumor. From (11), (12), (16) and (17) may be determined the electric field 
intensity ( E ϕ= −∇f ) and the electric current density ( J σ ϕ= − ∇f ) inside and outside the 




 are the current densities inside and outside, 
respectively) [Jiménez et al., 2011; Joa, 2010] and a wire of length L ( 1wJ
→
) and ( 2wJ
→
are the 
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where ∂ϕi/∂r and ∂ϕi/r∂θ are the radial and angular components of electric field vector for 
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nT  in (26) and (28) is given by (23). ∂ψi/∂r and ∂ψi/r∂θ are the radial and angular 
components of electric field vector for inside (i = 1) and outside (i = 2) the tumor, 
respectively. 




 (Fig. 7a), and 1wJ
→
  and  2wJ
→
 (Figure 7b) in 
different planes of the sphere(y = 0.1, 2 and 4 cm) parallel to the plane that contains the 
electrodes (y = 0 cm) for a point current source and a wire, respectively. The point current 
source is located in r0 = 4 cm (Figure 5a) whereas the wire with ends in a = 1 cm and b = 4 cm 
(L = 3 cm), as shown in Figure 5b. In both figures, we fix σ1 = 0.4 S/m, σ2 = 0.2 S/m, I = 5 
mA and R = 5 cm. Figures 7a and 7b reveal that there are differences between the 
distributions of  1pJ
→
  and  1wJ
→
; however, non significant differences are observed between 




 for different values of L. These differences are shown 
in Table 1 and are quantified by means of the maximum difference (Dmax, in A/m2) and the 
Root Means Square Error (RMSE, in A/m2), given by 
 max max wi piD J J











⎛ ⎞−⎜ ⎟⎝ ⎠= ∑ (i = 1, 2)  (32) 
www.intechopen.com
 Electrotherapy on Cancer: Experiment and Mathematical Modeling 
 
603 
where Jpi are the i-th calculated values of Jp(x,y) and Jwi are the i-th calculated values of 

































ℑ = ∑ : sum of the local current density over all points in a region of the 
surrounding healthy tissue) are used in the figures to compare the overall effect of changing 








). ℑ1 and ℑ2 are evaluated in a set of discrete points m1 
and m2, respectively, for both point current source and wire. ℑ1 is calculated in all tumor 
volume (m1 = 84 050 points) except in the points where the electrodes are inserted and in 
their vicinities. ℑ2 is also calculated in the surrounding healthy tissue (m2 = 35 301 points) 
comprehended in a spherical cap (between R (5 cm) and R + 2 (7 cm)). Table 2 reveals that 
ℑ1 and ℑ2 for the point current source are higher than those for the wire for all value of L. 
For the wire, it is observed that an increase of L results in a decrease of ℑ2 whereas inside to 
the tumor ℑ1 first decreases (up to L = 2 cm) and then increases. The behavior of ℑ1 with L is 





Fig. 7. Projections of 1pJ
→
 (in A/m2) and 2pJ
→
 (in A/m2) on planes y = 0.1, 2 and 4 cm for (a) 
one point electrode and (b) one electrode with form of wire ( 1wJ
→
, in A/m2, and 2wJ
→
, in 
A/m2). In each figure, the electrode polarity is positive (see Figure 6b). 
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Type of current source 
Electric current density in the 
tumor (A/m2) 
Electric current density in the 
surrounding healthy tissue 
(A/m2)
Dmax RMSE Dmax RMSE 




L = 0.5 cm 39744.718 3.0283 0.537 0.0003 
L = 1 cm 39763.700 3.0296 0.877 0.0006 
L = 1.5 cm 39771.290 3.0302 1.103 0.0007 
L = 2 cm 39775.324 3.0305 1.262 0.0008 
L = 2.5 cm 39777.820 3.0307 1.379 0.0009 
L = 3 cm 39779.514 3.0309 1.468 0.0010 
Table 1. Dmax and RMSE of 1wJ
→
 (in A/m2) and 2wJ
→
 (in A/m2) for a wire of length L respect 
to 1pJ
→
 (in A/m2) and 2pJ
→
 (in A/m2) generated by a point current source. L varies from 0.5 
to 3 cm. 
 
Type of current source ℑ1 (A/m2) ℑ2 (A/m2) 




L = 0.5 cm 1201.378 52.630 
L = 1 cm 1065.803 45.676 
L = 1.5 cm 1003.083 40.762 
L = 2 cm 996.252 37.128 
L = 2.5 cm 1045.207 34.344 
L = 3 cm 1182.477 32.155 
Table 2. ℑ1 (norm of 1pJ
→
 for a point electrode or 1wJ
→
 for a wire) and ℑ2 (norm of 2pJ
→
 for a 
point electrode or 2wJ
→
 for a wire). The wire length is L (between 0.005 to 0.030 m). ℑ1 and 
ℑ2 are given in A/m2. 








 for two point electrodes and two wires are 
shown in Figures 8a and 8b, respectively. The differences between these distributions are 
also quantified by means of Dmax and RMSE (Table 3) and the values of ℑ1 and ℑ2 evaluated 
in the same discrete points m1 and m2 are given in Table 4. A comparison of Figures 7 and 8 
reveals that an increase of the number of current sources (point or wire) results in a higher 
distribution of the electric current density lines in the tumor, being more evident for the 
electrodes in form of wire. 








, RMSE, Dmax, ℑ1 and ℑ2, the unities of y, a, b, L 
and R, given in cm, are converted to meter. 
The 3D-analytical expressions shown in this chapter allow the visualization of the potential, 
electric field strength and electric current density distributions generated for point current  
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Type of current source 
Electric current density in 
the tumor (A/m2) 
Electric current density in 
the surrounding healthy 
tissue (A/m2) 
Dmax RMSE Dmax RMSE 




L = 0.5 cm 39744.681 4.2824 0.564 0.0005 
L = 1 cm 39763.672 4.2845 0.918 0.0008 
L = 1.5 cm 39771.267 4.2854 1.152 0.0011 
L = 2 cm 39775.306 4.2858 1.317 0.0012 
L = 2.5 cm 39777.807 4.2861 1.440 0.0014 
L = 3 cm 39779.507 4.2863 1.537 0.0015 
Table 3. Dmax and RMSE of 1wJ
→
 (in A/m2) and 2wJ
→
 (in A/m2) for an array of two equal 
wires with different lengths L (between 0.5 to 3 cm) respect to those generated by an array of 
two point electrodes ( 1pJ
→
, in A/m2, and  2pJ
→
, in A/m2). 
 
Fig. 8. Projections of 1pJ
→
 (in A/m2) and 2pJ
→
 (in A/m2) on planes y = 0.1, 2 and 4 cm for (a) 
two point electrodes and (b) two electrodes with forms of wire ( 1wJ
→
, in A/m2, and 2wJ
→
, in 
A/m2). In each figure, one electrode is positive and another is negative (Figure 6c). 
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Type of current source ℑ1 (A/m2) ℑ2 (A/m2) 




L = 0.5 cm 1702.887 66.861 
L = 1 cm 1512.207 55.909 
L = 1.5 cm 1424.731 47.906 
L = 2 cm 1416.607 41.710 
L = 2.5 cm 1488.047 36.679 
L = 3 cm 1685.969 32.432 
Table 4. ℑ1 (norm of 1pJ
→
 for two point electrodes or 1wJ
→
 for two wires) and ℑ2 (norm of  
2pJ
→
 for two point electrodes or  2wJ
→
 for two wires). The wires are equals and have 
different lengths L (from 0.5 to 3 cm). ℑ1 and ℑ2 are given in A/m2. 
sources and radial arrays of electrodes with finite length. The results of the simulations 
reveal as these distributions in the tumor and its surrounding healthy tissue change in 
function of the tumor size, the positioning, number and polarity of the electrodes, and the 
difference of electrical conductivity between both tissues for, in agreement with previous 
theoretical studies [Aguilera et al., 2009; Aguilera et al. 2010; Čorović et al., 2007; Jiménez et 
al., 2011; Joa, 2010; Reberšek et al., 2008; Šel et al., 2003] and experimental reports [Chou et 
al., 1997; Ren et al., 2001; Serša et al., 1997; Turler et al., 2000; Xin et al., 1994; Yoon et al., 
2007]. 
3D-analytical expressions for the potential, electric field intensity and electric current 
density generated by wires completely inserted in the tumor along their diameters (plane y 
= 0 cm) are directly obtained from the application of this mathematical theorem and the 
parametric form of the curve given in equation (3). This justify that equations (16) and (17) 
are correct from the substitution of I for δI = I/(b-a)dr0 in equations (14) and (15) and then 
integrating these expressions from r0 = a to r0 = b, as is suggested in a previous study 
[Jiménez et al., 2011]. 
Non-uniform current density distributions are shown in a tumor (homogeneous conductor 
spheroid), as shown in Figures 7 (point electrodes) and 8 (electrodes with forms of wire). 
Normally, needles electrodes have highly non-homogeneous fields around their tips due to 
the sharp geometry. There are marked differences between the electric current density 
(potential and electric field) patterns generated by a point electrodes array and arrays of 
electrodes with length L, as is expected. Electric current density near the electrodes is also 
imaged for both point and wire arrays. Although the electric current density is maximum 
near electrodes, the magnitude of it fall even more rapidly towards the tumor edges in the 
perpendicular direction to the plane in which are the electrodes. Tumor regions unaffected 
by this electric current density re-grow after treatment. The singularities observed where the 
electrodes contact the tumor (large electric fields at the edges) can be avoided by grading the 
electric field near such edges. High current densities in the vicinity of the electrodes may 
result in tissue damage (example, coagulative necrosis), in agreement with our observations 
in mice [Cabrales et al., 2001; Ciria et al., 2004] and patients [Jarque et al., 2007]. Moreover, 
measurement of current density distribution near the current injecting electrodes provides 
information on the behavior of the electrode-tissue interface. Up to now, it has not discussed 
as depends on the electrotherapy antitumor effectiveness in function of the homogeneity 
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degree of the electric current density (electric field) induced in the tumor, essential aspect in 
the design of electrodes array and treatment planning. 
The insertion of the electrodes along tumor diameters is a particular electrodes array that we 
have used in some patients whose tumor thickness (depth) is smaller respect to their other 
two dimensions (skin, breast and vulva cancers) when the conventional therapies fail or 
cannot be applied, as shown in Figure 9. A direct current of 10 mA for 60 min is delivered to 
this patient with vulva cancer through 19 electrodes inserted with alternate polarities and it 
is generated by ZAY-6B electric device (manufactured in Chinese). Cannulae with trocar are 
inserted into the tumor mass under local anesthesia and the number of these depends on the 
tumor size (20 cm in diameter). The cannulae are fixed with a distance (gap) between them 
of 1 cm and disposed along a semi-circumference because for this zone pass important 
blood vessels. This distance should not be further than 1.5 cm apart because the tumor 
killing area around the needle is about 2 cm in diameter. Then the trocar are withdrawn and 
electrodes are inserted into the tumor through the cannulae to ensure that the electric field 
will cover all the tumor mass when the direct current passes through electrodes. After 
insertion of the electrodes, the cannulae are withdrawn to the edge of normal tissue by 
palpation with hand. These cannulae in the edge are insulation tubes to protect the normal 
tissue from the injury due to electrolysis. This procedure guarantees that the electrodes are 
completely inserted into the solid tumor to maximize tumor destruction with the minimum 
damage in the organism. The electrodes are then connected to the cathode or anode of the 
ZAY-6B device to supply the direct current that pass through the solid tumor. This 
procedure guarantees that the electrodes are completely inserted into the tumor. We use 
platinum needles because these are resistant to erosion and have high electric conductivity. 
The diameter of the needles is 0.07 cm and length 15 cm, values that justify why we assume 
in this mathematical approach that the electrode cross section is neglected respect to its 
length [Jiménez et al., 2011]. Saline solution and bleomycin are intratumor injected before 
and immediately after direct current application, respectively. It is made with the aim to 
potentiate the electrotherapy antitumor effectiveness, fact that is theoretically verified when 
the tumor conductivity increases with respect to that of the surrounding healthy tissue 
because the electric current density lines mainly distribute inside tumor and its periphery. 
We observe that as soon as direct current is connected to the electrodes, different 
electrochemical reactions influence the pH-value and can cause electrolysis of tumor tissue, 
which in turn, lead to the destruction of it. The tumor regression induced by this electrodes 
array is approximately 50 % one month after the application of this therapy. Minima adverse 
effects (events) are observed after direct current application, probably due to that the 
electrodes are inside tumor and this therapy is local. We are not observed immediate 
adverse events (first 24 hours after electrotherapy is applied); however, we have reported 
late adverse events (after 24 hours of applied electrotherapy), such as: necrosis on the 
ulcerated surface, erythema and slight edema at the area treated, inflammation because the 
cancerous tissue is being destroyed through this method of treatment. Immediately after 
treatment, we do not observe pain, fever, superinfections. The destroyed cancerous tissue is 
eliminated from the body and is replaced by scar tissue and then in the majority of the 
patients, we observe tissue granulation when the tumor is removed after this treatment 
[Jarque et al., 2007]. Similar results are reported in laboratory animal [Cabrales et al., 2001; 
Ciria et al., 2004; Haltiwanger, 2008; Mikhailovskaya et al., 2009; Sazgarnia et al., 2009; Vijh, 
2006] and human [Arsov et al., 2009; Haltiwanger, 2008; Jarque et al., 2007; Li et al., 2006; 
Salzberg et al., 2008; Vijh, 2006; Vogl et al., 2007; Xin et al., 2004; Yoon et al., 2007]. 
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Fig. 9. Patient with vulva cancer treated with electrotherapy. 
The use of this electrodes array stops the bloody flux of this patient for the vulva 
immediately after the electrotherapy application due to the haemostatic effect of the 
cathode. This fact may be explained because the cathode produces a tissue desiccation and 
therefore a control of the hemorrhage, in agreement with other results that demonstrate that 
the tumor blood flow is reduced by direct current action, fact that can be exploited to 
improve therapeutic outcome. It is well known that reductions in tumor blood flow can lead 
to an increase in hypoxia and extracellular acidification and as a result a cascade of tumor 
cell death will occur, due to a lack of nutrients, oxygen and an accumulation of catabolite 
products [Griffin et al., 1994; Haltiwanger, 2008; Xin et al., 2004]. As a result of this, this 
patient does not receive more blood transfusions post-treatment. This patient dies one year 
after the electrotherapy application due to multiple metastases in brain, lung and liver. 
In electrotherapy, the electrodes are generally inserted outside of the central plane [Cabrales et 
al., 2001; Cabrales et al., 2010; Ciria et al., 2004; Chou et al., 1997; Jarque et al., 2007; Ren et al., 
2001; Turler et al., 2000], constituting a limitation of the use of this radial electrodes array. This 
mathematical theorem solves the Problem 1 from the Problem 0 both harder and elastic 
needles. The solution of this problem becomes difficult in dependence on the complexity of 
this parametric form of the curve since more arduous is to solve the integral that appears in 
Equation (7). The simulations clearly demonstrate that analytical model is reliable and useful 
to search new electrode arrays that induce the highest electrotherapy effectiveness. New 3D-
mathematical formalisms are obtained in dependence of the parametric curve form (Equation 
3), which allow the insertion of the electrodes (hard or flexible) in any place of the tumor with 
arbitrary shape. This leads to solve problems more complex than that shown in a previous 
study [Jiménez et al., 2011] and to compare their electric current densities with those generated 
by other electrode arrays [Cabrales et al., 2001; Ciria et al., 2004; Chou et al., 1997; Jarque et al., 
2007; Jiménez et al., 2011; Joa, 2010; Xin et al., 2004; Yoon et al., 2007]. 
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Different authors report that there is a good correlation between the electric current density 
spatial distributions observed with different imaging techniques, those obtained by means 
of analytical and numerical solutions and experimental results [Miklavčič et al., 1998; Serša 
et al., 1997]. Among these techniques may be mentioned the Electric Current Density 
Imaging [Halter et al., 2007; Serša et al., 1997], Electrical Impedance Tomography [Saulnier 
et al., 2001], Magnetic Resonance Electrical Impedance Tomography [Seo et al., 2005], 
Magnetic Induction Tomography, Magnetoacoustic Tomography and Magnetoacoustic 
Tomography with Magnetic induction [Li et al., 2007]. These imaging techniques are useful 
to map spatial distribution of electric currents generated for any electrodes array in the 
tumor and its surrounding healthy tissue and to visualize the changes on electric current 
density patterns when the electrodes array parameters above mentioned are modified. 
These imaging techniques provide information on electrical conductivity inside an 
electrically conducting domain such as the human body and evidence that electric current 
density strongly depends on the placing, polarity and geometry of the electrodes, in 
agreement with our simulations. The quantification of the differences between the electric 
current densities obtained theoretically and experimentally is possible by means of an 
element average error (e) that can be evaluated by computing the integral over the element 
of the difference between the current density determined directly from the analytical 
expression (Ja) and the nodally averaged (interpolated) current densities over the region of 
support Vs (Js), given by ( )a s
Vs
e j j dV= −∫ . For this, it should be used the information 
provided by neighboring nodes to evaluate the magnitude of the higher order terms in the 
solutions that have been neglected. 
These facts indicate that these imaging techniques may be used to know as change the 
electrical conductivity and current density distribution before, during and after 
electrotherapy. As a result of this fact, we have an idea of the structural, functional and 
pathological conditions of the tissue and therefore provide valuable diagnostic information. 
For this reason, we include in the electric current density the information of the electrical 
conductivities of the tumor and surrounding healthy tissue, whose mean values may be 
measured by means of such imaging techniques above mentioned [Li et al., 2007; Saulnier et 
al., 2001; Halter et al., 2007; Seo et al., 2005; Serša et al., 1997]. This justifies why the bulk 
conductivities of both tissues are assumed constant in our mathematical approach. The bulk 
electrical conductivity values of heterogeneous and anisotropic tissues may also be 
calculated, with good approximation, by means of their electric conductivity tensor mean 
values [Sekino et al., 2009]. We believe that the higher electric conductivity of the tumor is 
along of the preferential direction of growth (major diameter of tumor with ellipsoidal 
shape); however, an experiment should be designed to demonstrate this hypothesis. 
Although the majority of the solid tumors are heterogeneous, all are homogeneous for 
volumes ≤ 3 cm3. Also, there are very few types of tumors (adenomas, adenocarcinomas, 
breast ductal carcinomas and sarcomas) with volumes > 3 cm3 that are homogeneous, fact 
explained because is only observed tumor mass due to the equilibrium between the growth 
and the tumor cells angiogenesis. When this equilibrium is broken, the tumors make more 
heterogeneous due to the presence of necrosis, infiltration to tissues, among other 
alterations. 
The fact that tumor conductivity is assumed higher than that its surrounding healthy tissue 
is justified because neoplasic tissues exhibit somewhat larger conductivity and permittivity 
values than homologous normal tissues due to that the water content is higher in the tumor 
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[Foster & Schwan, 1996; Haemmerich et al., 2003; Haemmerich et al., 2009; Miklavčič et al., 
2006; Ng et al., 2008; S.R. Smith et al., 1986, D.G. Smith et al., 2000]. We believe that the 
presence of other charged particles (molecules, ions and electrons) and blood vessels (due to 
the angiogenic process) may also increase the tumor conductivity and therefore more 
current flows for the tumor, as we corroborate with the simulations shown in this chapter. 
These simulations have not included the effects that produce the direct current application 
on the tumor electric conductivity (permittivity); however, it should change during and 
after electrotherapy application. This may be due to that in the tumor are induced changes 
in the ions concentration in the intracellular and extracellular fluids [Griffin et al., 1994], 
structure and cellular density [Vijh, 2006; Von Euler et al., 2003], molecular composition 
[Von Euler et al., 2003], in the cellular membrane [Vodovnik et al., 1992; Yoon et al., 2007], 
among others. For instance, it has been demonstrated that the tumor conductivity changes 
before and after of the tumor thermal ablation [Haemmerich et al., 2009]. The changes of the 
electric conductivity may be one of the indicators of tissues conditions (anatomical and 
functional) [Seo et al., 2005]. We believe that for electric current densities (electric field 
intensities) below the reversible threshold value should not change significantly the tumor 
conductivity, not occurring thus above this threshold. This may be in correspondence with 
the tumor re-grow observed for i/io < 2 and the stationary partial and complete responses 
for i/io ≥ 2, as shown in Figures 1 and 2 [Cabrales et al., 2008]. Hence, a detailed study 
should be carried out to know the explicit dependence between the electrical conductivity 
and the physiological parameters of the tumor. This may be used to establish an index for 
the prediction of the possible evolution of the patient during and after the direct current 
application (alone or combined). Also, an improved understanding of the theoretical basis of 
this dependence will enable structural features of the tumor tissue to be deduced from the 
experimental measurements. 
Although it is assumed that the fields and charges are non-time varying, and the magnetic 
field due to the current and the reaction of this field on the current, we do not discard that 
magnetic field due to the direct current intensity produce bioeffects in the tumor, mainly 
around electrodes, in agreement with other authors [Saulnier et al., 2001; Seo et al., 2005]. It 
is possible that this induced magnetic field induces mechanical forces and shear stresses in 
the tumor that in dependence of its strength and duration may also produce a wide variety 
of biological effects in cells and tumor tissue, such as: electrodiffusion/osmosis (various 
receptors, charged membrane molecules, can be transported along the cell surface) and 
change in transmembrane potential (voltage-gated channels may be opened to permit the 
transport of ions, such as calcium, into the cell) [Hart, 2008]. 
It is important to point out that the images obtained with these experimental techniques are 
important because reveal that the spatial distribution of electric currents do not depends 
only on electrode array but, also on their tissue contact, which is hard to control [Foster, 
1995; Serša et al., 1997]. The interaction electrode-tumor is not considered; however, it may 
have an important role in the skin heating. This heating is determined both by palpation 
with the hand and skin erythema of the patients with tumors treated with direct current 
[Jarque et al., 2007]. The tissue near of electrodes is heated mainly by the absorbed electrical 
energy, while regions further away may be heated by thermal conduction and/or some 
biophysic (electrochemical processes) induced into the tumor. As a consequence, the 
preferential heating of the tumor is governed by the electrical parameters near the electrode, 
whereas thermal parameters become increasingly important further away. An analysis of 
the energy (heat) absorbed by the tumor and its surrounding healthy tissue may be another 
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way to select these optima parameters. The absorbed energy can be calculated by means of 
the expression 21,2 1,2 1,2( / )Q j dVσ= ∫ , where Q, j and σ are the absorbed heat quantity, electric 
current density and electric conductivity in the medium, respectively. The sub-indexes 1 and 
2 represent to the medium 1 (tumor) and medium 2 (surrounding healthy tissue). Similar 
analyses of the absorbed energy quantity are carried out in radiotherapy and hyperthermia 
[Hall, 1988; Sadadcharam et al., 2008; Schaefer et al., 2008]. On the other hand, as the 
difference in electrical parameters between the tumor and its surrounding healthy tissue is 
substantial that might result in preferential heating of the tumor. This healing in 
dependence of its duration and intensity may be a result of the increase of the intratumor 
temperature that may provoke changes either directly or indirectly in the tissue dielectric 
properties and therefore irreversible damages in it [Foster, 1995]. The temperature 
dependence of the electrical conductivity may be related with damages in the tumor. In 
order to correctly mimic the absorbed energy in the tumor and its surrounding healthy 
tissue during electrotherapy exposure, a three dimensional model must be used. 
Model tumor system as a spheroid is assumed for the following reasons: 1) the spheroid 
system has been applied to a number of problems in cancer and it is a model of a solid 
tumor in vitro and in vivo. 2) This system mimics many of these tumor characteristics and 
provides a rapid, useful, and economical method for screening sensitizers and 
chemotherapeutic agents because it is intermediate in complexity between single-cell in 
vitro culture and tumors in experimental animals. 3) The spheroid system is simpler, more 
reproducible, more economical, and easier to manipulate than animal tumors, and yet the 
cells can be studied in an environment that includes the complexities of cell-to-cell contact 
and nutritional stress from diffusion limitations that are characteristic of a growing tumor. 
4) Some cells, notably several rodent tumor cell lines, such as chinese hamster V79 lung 
cells, mouse EMT6 mammary and R1F fibrosarcma cells, and rat 9L brain tumor cells grow 
as spheroids. At each successive division the daughter cells stick together, and the result is a 
spherical clump of cells that grows bigger and bigger with time. 5) Many types of human 
tumor cells can be cultured as spheroids with a wide spectrum of morphological appearance 
and growth rates. 6) Human tumor cell spheroids maintain many characteristics of the 
original tumor from the patient or of the some cells grown as xenografts. Human tumors 
successfully grown as spheroids include thyroid cancer, renal cancer, squamous carcinoma, 
colon carcinoma, neuroblastoma, human lung cancer, glioma, lymphoid tumors, melanoma, 
and osteosarcoma [Hall, 1988]. 
A feasible way to optimize 3D-electrode arrays is combining all the electrodes array 
parameters such that the electric current density in the tumor is the permissible maximum 
and that induced in the surrounding healthy tissue is smaller than 10 mA/m2. For this, we 
suggest the following procedure: first, the parameters are automatically selected so that the 
electric current density in the surrounding healthy tissue is smaller than 10 mA/m2. This 
guarantees the safety of the electrotherapy (Phase I of a Clinical Trial) and that the adverse 
effects in the organism are minima (Phase II of a Clinical Trial). Second, the selection of the 
optimum parameters depends on the electric current density (electric field strength) that 
induces the biggest tumor destruction (Phase III of a Clinical Trial), which may be 
experimentally verified by means of an experiment, in which is obtained the higher 
electrotherapy antitumor effectiveness, the maximum survival and life quality of the patient 
(laboratory animal). It evaluates the contributions of each parameter (alone or combined 
with other) and requires a significant consumption of calculation time for the parameters 
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quantity involved in these equations. For the implementation of this way, we should take 
into account that exposure of a biological cell to electric current density (electric field) can 
lead to a variety of biochemical and physiological responses. For this, it is required to know 
what electric current density values provoke significant biological effects: below 1 mA/m2 
(there are not biological effects); 1-10 mA/m2 (minimum biological effects, which are not 
significant); 10-100 mA/m2 (possible biological effects without risk to the health); 100-1000 
mA/m2 (biological effects without possible risk to the health) and above 
1000 mA/m2 (biological effects with proven risks to health) [International Commission on 
Non-Ionizing Radiation Protection, 1998]. This is very important because the electrotherapy 
effectiveness is highly depend on the magnitude and spatial distribution of electric currents 
flowing through the tumor and its surrounding healthy tissue, in agreement with other 
authors [Serša et al., 1997]. 
The knowledge of the optimum distributions of current density vector in the tumor and its 
surrounding healthy tissue allows the optimum design of noninvasive electromagnetic 
techniques for the cancer treatment. Several authors report that the ultralow-frequency 
extremely weak alternating component of combined magnetic fields exhibits a marked 
antitumor activity [Novikov et al., 2009]. These fields will avoid the insertion of electrodes in 
the tumor and therefore the little trauma that this provoke in the patients treated with 
electrotherapy. Weak magnetic fields activate the system of antitumor immunity (i.e., 
production of Tumor Necrosis Factor, activation of macrophages, among other) and 
produce reactive oxygen species, as is also observed on electrotherapy [Cabrales et al., 2001; 
Serša et al., 1994; Serša et al., 1996; Watemberg et al., 2008]. 
Different authors have experimentally evaluated the influence of direct current intensity 
[Ciria et al., 2004; Cabrales et al., 2010; Chou et al., 1997, Ren et al., 2001; Xing et al., 2004] 
and electromagnetic field [Novikov et al., 2009] on tumor growth kinetic; however, the 
weight of the different parameters of an electrodes array in it has not been widely discussed. 
Consequently, it is possible to simultaneously know, previous treatment, the possible tumor 
evolution in the time and the electric current density (potential, electric field intensity) 
distributions in the tumor and its surrounding healthy tissue and therefore the highest 
electrotherapy antitumor effectiveness. This improving therapy may be obtained when the 
tumor reaches its complete cure (complete remission or stationary partial response) 
[Cabrales et al., 2008; Cabrales et al., 2010] or the higher tumor growth delay (highest 
survival of the patients with good life quality and/or bigger disease free interval) [Ciria et 
al., 2004; Chou et al., 1997; Jarque et al., 2007; Ren et al., 2001; Xin et al., 2004; Yoon et al., 
2007]. The evaluation of it requires to quantify different biological parameters, such as: 
tumor regression percentage, mean doubling time, survival rate, antibody responses, 
cellular responses, apoptosis, necrosis, histological examination, immune responses, and 
gene expressions, among others. This will contribute to elucidate the direct current 
antitumor mechanism. 
The tumor complete response suggests that its growth kinetic is completely reversible, as 
shown in Figure 10 for fibrosarcoma Sa-37 tumor [Cabrales et al., 2010]. This behaviour is 
obtained from the experimental data [Ciria et al., 2004] and the analysis of the first and 
second parts of the tumor growth kinetic by means of the use of the modified Gompertz 
equation [Cabrales et al., 2010]. The first part comprehends the time that elapses from the 
initial moment at which tumor cells are inoculated in the host (t = 0 days) up to 15 days that 
is the moment of direct current application, when the tumor volume reaches Vo = 0.5 cm3), 
whereas the second part is the time that elapses from Vo up to the end of the experiment, 
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that is, time after direct current application. Both parts are obtained using the interpolation 
process and the time step is Δt = 1/3 days. The parameters i, Ǐ, ǐ, Ǒ and io are above defined 
and obtained from fitting the experimental data [Cabrales et al., 2008]. The analysis of these 
two parts reveals the existence of two tumor volumes that suggests the unavoidable tumor 
destruction: in the first, the tumor does not return to its state before direct current treatment, 
Vid, and therefore complete (stationary partial) response is reached. In the second, the small 
fraction tumor that survives to direct current action is completely destroyed by the 
organism, Vd, aspect that may suggest that the therapies for the cancer, including the 
electrotherapy, should be directed to that the tumor always reaches Vd. New investigations 
have been derived starting from this hypothesis. 
In the case that complete remission (stationary partial response) of tumor is not reached 
after alone direct current stimulus, the electrotherapy should be directed to increase the 
survival and quality of life of patients (laboratory animals). First this, we should know the 
exact time in that electrotherapy may be repeated (time for which the tumor volume is 
between Vo and the minimum volume observed in tumor growth, Vmin), as shown in Figure 
11 [Cabrales et al., 2010]. When the tumor volume reaches this value there is a change of 
both slope and sign of the first derivate of the tumor volume (corresponding to minimum 
value of this first derivate), aspect that may indicate a tumor response (reorganization 
and/or activation of the growth and protection mechanisms) to the direct current action, 
whose intensity is not adequate to significantly perturb to it. This fact may be explained 
because the biological systems, as the tumors, respond to the external perturbations in order 
to reach their maxima survival. As a result, the electrotherapy should be repeated or 
combined with other therapies when the first derivate of the tumor volume changes of slope 
and sign because the tumor cannot be reorganized, in agreement with the current tendency 
of repeating weekly (every fifteen days) this therapy of 2 to 4 times. This constitutes a novel 
statement because establishes that this therapy should not be applied when the tumor 
volume reaches Vmin, as is implemented for the treatment of patients at present [Jarque et al., 
2007; Xin et al., 2004]. It is possible a fractionated therapy may lead to the complete 
(stationary partial) remission. 
 
 
Fig. 10. Direct current-perturbed fibrosarcoma Sa-37 tumor growth kinetic for the 
parameters: Vo = 0.5 cm3, i = 14.8 mA, Ǐ = 0.006 days-1, ǐ = 0.207 days-1, Ǒ = 0.189 days-1, io = 
1.080 mA and Δt = 1/3 days. Time dependence of tumor volume (left picture). First derivate 
of tumor volume versus tumor volume (right picture). 
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Fig. 11. Direct current-perturbed fibrosarcoma Sa-37 tumor growth kinetic for the 
parameters: Vo = 0.5 cm3, i = 11.7 mA, Ǐ = 1.584 days-1, ǐ = 0.076 days-1, Ǒ = 0.107 days-1, io = 
7.431 mA and Δt = 1/3 days. Time dependence of tumor volume (left picture). First derivate 
of tumor volume versus tumor volume (right picture). 
The inclusion of the other electrodes array parameters, in addition to direct current 
intensity, in the tumor growth kinetic may efficiently lead to complete (stationary partial) 
response for smaller direct current intensities. 
The knowledge of these two parts of the tumor growth kinetic is important to reveal further 
information of it and in the therapeutic planning, as is widely discussed in a previous study. 
Similar results for fibrosarcoma Sa-37 tumor are also found Ehrlich tumor (results not 
shown) [Cabrales et al., 2010]. 
By optimizing the electrodes array parameters and those of the tumor growth kinetic (for 
instance, modified Gompertz equation), the efficiency of electrotherapy might be improved 
further. This procedure will have to be tested in larger animals to assess the usefulness and 
safety of electrotherapy in vivo for the future application to humans. 
In spite of the considerable progress of electrotherapy, a number of challenges remain for the 
future. The future strategies include (a) increasing the volume of destroyed tissue at a single 
treatment session (b) the integration of electrotherapy with the other in-site tumor antitumor 
techniques and (c) the necessity of to incorporate realistic geometric, conductivity, and, 
eventually anisotropic information in order to reach the highest electrotherapy effectiveness. 
3. Conclusion 
In conclusion, electrotherapy of low-level direct current is promissory for cancer treatment. 
The electric current density (potential and electric field strength) analysis results can be used 
for assessing effective treatment parameters of tumor. The use of this mathematical 
approach and the theorem provide a rapid way to propose different optimum electrode 
arrays in dependence of location, depth, shape and size of the solid tumors with the purpose 
of obtaining the higher antitumor effectiveness and as a result to implement the 
electrotherapy in the Clinical Oncology. 
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